The Emerging Role of IGF2BP2 in Cancer Therapy Resistance: From Molecular Mechanism to Future Potential DOI Open Access

D Li,

Shi‐Qi Hu, Jiarong Ye

и другие.

International Journal of Molecular Sciences, Год журнала: 2024, Номер 25(22), С. 12150 - 12150

Опубликована: Ноя. 12, 2024

Tumor resistance is one of the primary reasons for cancer treatment failure, significantly limiting options and efficacy therapies. Therefore, overcoming has become a critical factor in improving outcomes. IGF2BP2, as reader m6A methylation, plays pivotal role post-transcriptional regulation RNA through methylation sites. It not only contributes to initiation progression but also key tumor drug resistance. This review provides comprehensive summary mechanisms by which IGF2BP2 therapy resistance, with aim chemotherapy treatment. Advancing research this area crucial developing more effective therapies that could improve quality life patients.

Язык: Английский

The role of retinal pigment epithelial senescence and the potential of senotherapeutics in age-related macular degeneration DOI
Yingying Chen,

Feipeng Jiang,

Yue Zeng

и другие.

Survey of Ophthalmology, Год журнала: 2025, Номер unknown

Опубликована: Март 1, 2025

Язык: Английский

Процитировано

0

METTL3‐mediated TIM1 promotes macrophage M1 polarization and inflammation through IGF2BP2‐dependent manner DOI

Xianrong Du,

Yinguang Guo,

Xiaoqin Zhao

и другие.

Journal of Biochemical and Molecular Toxicology, Год журнала: 2024, Номер 38(10)

Опубликована: Сен. 12, 2024

Macrophage polarization and inflammation may play an important role in the development of sepsis. T-cell immunoglobulin mucin 1 (TIM1) has been demonstrated to promote macrophage inflammatory responses. However, whether TIM1 regulates affect sepsis remains unclear. Human monocytic leukemia cell line was induced into macrophages, followed by stimulated with LPS IL-4 induce M1 M2 polarization. The expression levels TIM1, methyltransferase 3 (METTL3), insulin like growth factor 2 mRNA binding protein (IGF2BP2) were examined qRT-PCR western blot. IL-6, IL-1β, TNF-α tested ELISA. CD86

Язык: Английский

Процитировано

3

The Emerging Role of IGF2BP2 in Cancer Therapy Resistance: From Molecular Mechanism to Future Potential DOI Open Access

D Li,

Shi‐Qi Hu, Jiarong Ye

и другие.

International Journal of Molecular Sciences, Год журнала: 2024, Номер 25(22), С. 12150 - 12150

Опубликована: Ноя. 12, 2024

Tumor resistance is one of the primary reasons for cancer treatment failure, significantly limiting options and efficacy therapies. Therefore, overcoming has become a critical factor in improving outcomes. IGF2BP2, as reader m6A methylation, plays pivotal role post-transcriptional regulation RNA through methylation sites. It not only contributes to initiation progression but also key tumor drug resistance. This review provides comprehensive summary mechanisms by which IGF2BP2 therapy resistance, with aim chemotherapy treatment. Advancing research this area crucial developing more effective therapies that could improve quality life patients.

Язык: Английский

Процитировано

1